HomeAI · summaries
Storia in 2 fonti
Ireland falls further behind EU peers on innovative medicines access | Euractiv
Rare disease wait times rise to 801 days despite new framework agreements and record investment
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
euobserver.com
The EU’s rare disease lottery: why your treatment depends on whether you live in Ireland, Germany or Malta
Why are hundreds of rare disease patients like me still waiting for European Medicines Agency approved drugs?
- ·
euractiv.com
Ireland falls further behind EU peers on innovative medicines access | Euractiv
Rare disease wait times rise to 801 days despite new framework agreements and record investment
- ·
Ireland lags EU peers on clinical trials despite rise in activity | Euractiv
Pharmaceutical industry calls for structural reforms as Dublin ranked slowest in bloc for trial start-up times, and 14th out of 27 for per capita clinical trial activity in 2025